CTRI/2023/04/052114招募中4 期
A clinical trial to assess the efficacy of the Ayurvedic Kneesol oil to claim substantiation in Rheumatoid arthritis on comparison with Dabur Rheumatil oil and Diclofenac gel (1% w/w) or spray (1 mg): An open labelled randomized single centric comparative three arm study.
Madhusudan Healthcare0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Aged between 18 and 75 years old of either sex.
- •2. If rheumatoid arthritis is moderately or severely active, the disease activity during the screening period and the baseline period must meet the following criteria:
- •Swollen joints count (SJC) >= 6 (based on 66 joint count) and tender joints count (Tender joints count: TJC) >= 6 (based on 68 joint count) (if the same joint has both swelling and Tenderness, this joint is included in the counts of swollen joints and tender joints).
- •3. Morning stiffness in and around the joints for at least 6 weeks which is lasting at least 1 hr before the maximal improvement.
- •4. Take medically approved non-drug contraceptive measures (such as drug-free intrauterine devices, condoms, female sterilization, and male sterilization) during the entire trial period and at least 3 months after the end of the medication, and no Pregnancy planner.
- •5. Those who understand, voluntarily sign the informed consent form, and comply with the requirements of the research plan.
排除标准
- •1. Those who have received any medical supportive treatments (such as whitening drugs, drugs for anaemia (except folic acid), liver-protecting and enzyme-lowering drugs, blood transfusions, etc.) within 2 weeks before screening.
- •2. Patients with acute myocardial infarction, unstable angina pectoris, stroke, and cardiac insufficiency within 6 months before screening.
- •3. The kidney, lung, digestive tract, nervous system and other serious diseased individuals (such as: poorly controlled severe diabetes, hypertension, interstitial pneumonia, obstructive Lung disease, bronchospasm, etc.), the investigator judged that it is not suitable to join the research.
- •4. Those who have a history of smoking, alcoholism, or drug abuse within 12 months before screening.
- •5. People with other primary or secondary immunodeficiencies in the past or at the time of screening, including patients with a history of HIV infection and positive HIV test results.
- •6. Patients administering any herbal or topical herbal pain relief agents.
- •7.The patients with current or recent corticosteroid treatment; or ongoing treatment with anticoagulants, hydantoin, lithium, steroids, methotrexate and colchicines or concurrent pain relieving medication such as antipyretics, analgesics, tranquilizers, hypnotic, excessive alcohol, NSAIDs.
- •8. Those who have participated in other clinical studies within 3 months before screening.
- •9. Women who are preparing for pregnancy, pregnancy, lactation, or who become pregnant during the planned trial period
研究者
相似试验
尚未招募
2 期
Effect of the test product in reducing dark spotsCTRI/2024/03/064874Hindustan Unilever Limited
进行中（未招募）
4 期
A study to evaluate the efficacy of Madhuyashti,Khadira and Shankha Bhasma on AcidityCTRI/2018/05/013941Rajiv Gandhi Govt Post Graduate Ayurvedic College and Hospital
已完成
3 期
effect of Ayurvedic intervention in COVID-19 positive casesCTRI/2020/05/025276Ch Brahm Prakash Ayurved Charak Sansthan54
已完成
2 期
To check the efficacy of certain ayurvedic medicines in cases of Osteoarthritis(Joint-Pains)CTRI/2018/02/011893Principal RGGPG Ayurvedic College and Hospital Paprola20
尚未招募
3 期
A CLINICAL STUDY TO EVALUATE THE EFFICACY OF AYU-ANO-D-GEL(LOCALLY) ALONG WITH HARITAKI CHURNA VATI (ORALLY) IN THEMANAGEMENT OF PARIKARTIKA W.S.R. TO FISSURE IN ANO.CTRI/2024/07/070027Damini Raut